These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody. Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755 [TBL] [Abstract][Full Text] [Related]
4. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein. Ntumngia FB; King CL; Adams JH Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913 [TBL] [Abstract][Full Text] [Related]
5. Human antibodies against DBP. Richards JS; Ramsland PA Nat Microbiol; 2019 Sep; 4(9):1428-1429. PubMed ID: 31439930 [No Abstract] [Full Text] [Related]
7. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein. Ntumngia FB; Adams JH Clin Vaccine Immunol; 2012 Jan; 19(1):30-6. PubMed ID: 22116684 [TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand. Chootong P; Panichakul T; Permmongkol C; Barnes SJ; Udomsangpetch R; Adams JH PLoS One; 2012; 7(4):e35769. PubMed ID: 22558221 [TBL] [Abstract][Full Text] [Related]
9. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain. George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH mSphere; 2019 May; 4(3):. PubMed ID: 31092602 [TBL] [Abstract][Full Text] [Related]
10. Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC. Batchelor JD; Malpede BM; Omattage NS; DeKoster GT; Henzler-Wildman KA; Tolia NH PLoS Pathog; 2014 Jan; 10(1):e1003869. PubMed ID: 24415938 [TBL] [Abstract][Full Text] [Related]
11. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Chootong P; Ntumngia FB; VanBuskirk KM; Xainli J; Cole-Tobian JL; Campbell CO; Fraser TS; King CL; Adams JH Infect Immun; 2010 Mar; 78(3):1089-95. PubMed ID: 20008533 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II. Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294 [TBL] [Abstract][Full Text] [Related]
13. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission. Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284 [TBL] [Abstract][Full Text] [Related]
14. The association of Duffy binding protein region II polymorphisms and its antigenicity in Plasmodium vivax isolates from Thailand. Chootong P; McHenry AM; Ntumngia FB; Sattabongkot J; Adams JH Parasitol Int; 2014 Dec; 63(6):858-64. PubMed ID: 25108177 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes. Dickey TH; McAleese H; Salinas ND; Lambert LE; Tolia NH Protein Sci; 2024 Aug; 33(8):e5095. PubMed ID: 38988315 [TBL] [Abstract][Full Text] [Related]
16. Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II. Wongkidakarn S; McHenry AM; Sattabongkot J; Adams JH; Chootong P PLoS One; 2016; 11(5):e0154577. PubMed ID: 27145131 [TBL] [Abstract][Full Text] [Related]
17. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys. Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763 [TBL] [Abstract][Full Text] [Related]